- Home
- / GT Apeiron Therapeutics
GT Apeiron Therapeutics
Total Funding
$27 M
GT Apeiron Therapeutics Summary
Company Summary
- Overview
- GT Apeiron Therapeutics is a biotech company. The company utilizes state-of-the-art technologies for drug discovery.
- Type
- Private
- Status
- Active
- Founded
- 2019
Table of Contents
Footer menu
Product
- Intelligence Suite
- Supplier Intelligence Platform
- Craft Intelligence Portal
- Craft API
- Craft for Teams
- Supplier Intelligence Platform
- Craft Alerts
- Craft N-Tier Mapping
- Craft Risk Hub
- Chrome extension
Resources
© Craft.co 2026